| [1] | Zong Z., Xie F., Wang S., et al. (2024). Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell 187:2375−2392.e33. DOI:10.1016/j.cell.2024.04.002 |
| [2] | Wang X., Lin C., Zhang Y., et al. (2026). Excess intracellular lactate represses mRNA translation and tumor progression through lactate-tRNA charging. Mol. Cell 86:3529−3544.e9. DOI:10.1016/j.molcel.2026.07.026 |
| [3] | Ju J., Zhang H., Lin M., et al. (2024). The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer. J. Clin. Invest. 134:e174587. DOI:10.1172/jci174587 |
| [4] | Pataskar A., Champagne J., Nagel R., et al. (2022). Tryptophan depletion results in tryptophan-to-phenylalanine substitutants. Nature 603:721−727. DOI:10.1038/s41586-022-04499-2 |
| [5] | Zhang W., Lahry K., Cipurko D., et al. (2025). Two microbiome metabolites compete for tRNA modification to impact mammalian cell proliferation and translation quality control. Nat. Cell Biol. 27:1812−1826. DOI:10.1038/s41556-025-01750-6 |
| Zhang C., Yu X., Singh S., et al. (2026). When tRNA mischarging becomes a metabolic brake on translation. The Innovation Oncology 1:100039. https://doi.org/10.59717/j.xinn-oncol.2026.100039 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Lactate-dependent tRNA mischarging links glycolytic overflow to translational control